SciLifeLab (www.scilifelab.se) is a Swedish national centre for large scale and hypothesis-driven research within molecular bioscience. SciLifeLab is collaboration between four universities in Uppsala and Stockholm: Uppsala University, The Royal Institute of Technology, Karolinska Institutet and Stockholm University. Uppsala University is a comprehensive research-intensive university with a strong international standing. Our mission is to pursue top-quality research and education and to interact constructively with society. Our most important assets are all the individuals whose curiosity and dedication make Uppsala University one of Sweden’s most exciting workplaces. The Department of Immunology, Genetics and Pathology at Uppsala University (www.igp.uu.se) has a broad research profile with strong research groups focused on cancer, autoimmune and genetic diseases. A fundamental idea at the department is to stimulate translational research and thereby closer interactions between medical research and health care. The staff amounts to approximately 340 employees, out of which 100 are PhD-students, and there are in total more than 600 affiliated people.
Our research group is jointly supported by SciLifeLab and Uppsala University. We aim to dissect the negative immune regulatory network in immune cells and cancer cells to uncover novel mechanisms that could broaden the clinical benefits of cancer immunotherapy. We will achieve this by combining our pre-clinical research expertise in cancer immunology with the pioneering technology platforms at SciLifeLab. Moreover, we will maintain close partnership with oncologists and industry collaborators in order to evaluate the clinical relevance and druggability of our research findings. In particular, we have a special interest in cancer types where immunotherapy is less explored, e.g. childhood solid cancers.
What we offer
• To be one of the founding members of the research team with the power to shape the highly interdisciplinary and translational research projects.
• To be supported by a strong research network at Uppsala University, SciLifeLab, Karolinska Institute and esteemed international experts.
• To gain insights and transferrable skills in early drug discovery.
• Dedicated time to discuss your career needs and developmental plans.
• A recent PhD degree in relevant research areas. Candidates within 3 months of their PhD dissertation may also be considered.
• Solid experimental background including in vitro cell-based assays, western blotting, qPCR, ELISA and flow cytometry.
• Passionate and dedicated in pursuing a scientific career and show an interest in translational cancer immunology.
• Confident in conducting scientific discussions in English.
• Publication(s) as a lead author in peer-reviewed scientific journals.
• Hands-on experiences to design and execute experiments using mouse models.
• Proven experiences in advanced immunological assays such as multi-colour (>10) flow cytometry, primary immune cell isolation and functional assay development, etc.
• Experiences with CRISPR/Cas9 precise genome editing and bioinformatics analysis tools.
This is a 2-year career development opportunity designed for recent PhD graduates and is exempted from taxation. The monthly scholarship will be discussed and approved by the head of the department. Extension of the position after 2 years is possible and will be determined individually.
Please send your CV including a complete list of publications and a motivation letter (1-2 pages) to summarise your research background and interests.
Start date: 2019-10-01 or as agreed
For more information, please contact Yumeng.Mao@scilifelab.uu.se
Uppsala University strives to be an inclusive workplace that promotes equal opportunities and attracts qualified candidates who can contribute to the University’s excellence and diversity. We welcome applications from all sections of the community and from people of all backgrounds.